About JSR Life Sciences

Learn what we are all about

JSR Life Sciences brings together the deep biochemical knowledge and understanding of human disease, expertise in drug discovery and development, and access to capital into a single, integrated framework that creates value for our customers.

JSR supports the drug discovery and development needs of our partners with tailored solutions that identifies and applies the right tools and technologies to support their unique therapeutic programs. From de-risking molecule selection and accelerating biologic development timelines, to increasing clinical success rates and developing in vitro diagnostics, JSR Life Sciences is committed to guiding our customers’ innovative science along the path to becoming life-saving medicines.

Accelerating Our Life Sciences Footprint

We offer our partners best-in-class research products and services for outsourced drug discovery and development. With our proprietary products and services and through our affiliate companies, JSR has a global presence including 28 sites in seven countries.

Our Affiliates

We leverage the core competencies of our affiliates to create integrated solutions that are designed to guide our partners’ programs from the lab through commercialization.

Crown Bioscience
Contract research organization with advanced technology for precision medicine

Similis Bio
Similis Bio jump-starts your biosimilar program with pre-qualified analytical methods, detailed reference product characterization & off-the-shelf assets.

MBL
Biomarker discovery for companion and in vitro diagnostics

KBI Biopharma
Global contract development and manufacturing organization with advanced analytical capabilities


JSR’s specialty life science research products include:

Amsphere A3, a protein A chromatography resin for advanced protein separation

Magnosphere hydrophilic and hydrophobic microparticles for research and in vitro diagnostics use

JSR Life Sciences is a business unit of JSR Corporation, a multinational advanced materials and solutions company based in Japan.

Latest JSR Life Sciences news

Prostate Cancer Breakthrough: Crown Bioscience Collaborates in €1.75M Eurostars Funded Project for Novel Liquid Biops...

Crown Bioscience, part of JSR Life Sciences, joins a €1.75M Eurostars project to develop a novel liquid biopsy for prostate cancer, enhancing treatment.

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

Crown Bioscience enhances its global presence with the expansion of its Singapore facility, featuring cutting-edge oncology models and imaging capabilities.

JSR Life Sciences to Launch Amsphere™ A+, a Next-Generation Protein A Resin for Antibody Drug Purification

Amsphere™ A+ enhances antibody drug production with advanced polymer technology and high binding capacity, debuting at BPI 2024 and BioJapan.

Receive JSR Life Sciences news on your RSS reader.

Or subscribe through Atom URL manually